Kymera Therapeutics, Inc. (KYMR) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Kymera Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.179 Good day, everyone. My name is Stefan and I'll be your conference operator today. 00:00:05.179 -- 00:00:09.485 At this time, I'd like to welcome you to the Chimera Therapeutics first quarter 2026 00:00:09.485 -- 00:00:14.753 results call. All lines have been placed on mute to prevent any background 00:00:14.753 -- 00:00:16.215 noise. 00:00:16.215 -- 00:00:19.620 After the speaker's remarks, there'll be a question and answer session. 00:00:19.620 -- 00:00:24.407 If you would like to ask a question during this time, and if you've joined via the webinar, 00:00:24.407 -- 00:00:30.389 please use the raised hand icon, which can be found at the bottom of your webinar application. 00:00:30.389 -- 00:00:36.455 If you've joined by phone, please dial star nine on your keypad to raise your hand. 00:00:36.455 -- 00:00:41.100 At this time, I'd like to turn the call over to Justine Konigsberg, 00:00:41.100 -- 00:00:44.501 Vice President of Investor Relations. 00:00:44.964 -- 00:00:49.108 Good morning and welcome to Chimera Therapeutics quarterly update conference call. 00:00:49.108 -- 00:00:53.833 Joining me today are Nello Mainalfi, our founder, president, chief executive officer, 00:00:53.833 -- 00:00:58.823 Jared Golub, our chief medical officer, and Bruce Jacobs, our chief financial officer. 00:00:58.823 -- 00:01:02.670 Following our prepared remarks, we will open the call for questions from our covering 00:01:02.670 -- 00:01:07.680 analysts. Please use the raise hand icon to indicate you'd like to ask a question, 00:01:07.680 -- 00:01:12.489 and we kindly ask that you limit your question to one so we can accommodate everyone. 00:01:12.489 -- 00:01:16.236 But before we begin, I would like to remind you that today's discussion will include 00:...